Clarify Inc. Expands into Central and South​ American Markets with AI Medical Devices

Clarify Inc., a leading AI medical imaging solution​ specialist, is making a significant impact in the Central and South American⁣ markets ⁣through the ‘Central and South‌ American ‌Electrical and Electronic Communication Medical Device⁢ Certification and Localization Support‌ Project’ of the Small⁣ and Medium Business Administration ‌(SMB).

This support project enables selected innovative ⁤companies to quickly supply their key products ​to the Central ⁢and ‌South American medical device markets by matching them ⁢with local agents, supporting product certification​ and registration, ‌and⁣ providing⁢ information related⁤ to⁣ localization.

Clarify is targeting Mexico and ⁢Chile as its main targets for this project and is seeking to register with the Federal Sanitary Risk ⁢Management Committee⁣ of the Mexican Ministry of Health. ⁢With the help ⁤of ANCE, a local Mexican testing and certification agency, the Korea Testing Laboratory, and SMBC Mexico City Global Business Center (GBC), ‌SMBC is⁤ expediting related procedures.

The Latin⁤ American⁣ market is an important ⁣market where ⁤demand for AI-based medical devices ⁣is rapidly increasing due​ to population growth and economic growth. Especially in areas with low accessibility to medical services, there ​is a‌ high⁢ demand⁤ for low-cost, high-efficiency medical solutions, and Clarify’s AI medical imaging solution is expected to be the⁤ optimal product to meet ⁣these needs.

A ClariFi product ‍briefing session held at ⁤Univ. Autonoma, a private university in​ Chile.

Prior to ⁢this, a ⁢larger number ⁤of​ people ​than ‌expected ‍attended the Clarify product briefing held at the private Chilean university​ Univ. Autonoma,​ showing high expectations for the AI ​​medical imaging solution. This ⁣is interpreted as a positive‍ sign that⁣ Clarify’s⁣ products are receiving great attention in the​ Central and South ⁣American markets and for successful market‍ entry.

ClariCT.AI, Clarify’s ⁢flagship‌ product, is an AI-based CT image noise removal⁢ solution that ‍reduces noise in⁢ low-dose CT scans to improve image clarity. This helps ​medical professionals⁤ make accurate diagnoses while minimizing ​radiation exposure and ‍extending the life of CT equipment, ⁢improving⁣ hospital operational ⁢efficiency.

ClariCT.AI is a proven ​product that has⁢ already received FDA and⁣ CE certification, securing competitiveness in the global medical ​device market.⁣ Clarify has already successfully ​launched products in the US and Europe ⁢and has expanded its global supply chain.

We have signed a product ⁣supply contract ​with Siemens Healthineers in Germany, and are⁤ also consolidating⁣ our ‍position in the global market by signing contracts with⁢ global AI marketplace companies such as MS⁣ Nuance, Blackford in the UK, and Bayer in Germany. In addition, we are expanding product supply to Hong Kong, Hainan, Singapore, etc. in⁣ cooperation with Radcon, a‍ medical device distribution company, to enter the Asian market.

CEO Kim Jong-hyo ​said, “It is very meaningful that ⁣we have secured an important foothold in the ​Central and South American market through this support from the ⁣SMEs and Startups Agency,” and added, “We will⁤ expand our ‍global supply chain in ⁢the Asian, North American, ‌and European markets, including Central ⁣and South America, and establish ⁣ourselves ⁢as a leading ‌global AI medical device company.”

Meanwhile, Clarify plans ⁤to continuously strengthen‌ its ⁣competitiveness in the global market and achieve successful results in more regions based on ⁣its innovative AI technology.